Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Leadership History
3 leaders · Full leadership timeline
Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.
Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
Chairman and Chief Executive Officer
Leads J&J's post-Kenvue focus on Innovative Medicine and MedTech.
Former Chairman and Chief Executive Officer
Led J&J through portfolio expansion, COVID-era healthcare demand, and the consumer-health separation setup.
Co-founder
Co-founded the company and helped establish its medical-products roots.
Johnson & Johnson faces patent expirations, biosimilar pressure, drug pricing scrutiny, product litigation, regulatory risk, R&D productivity demands, and MedTech competition.
Joaquin Duato is the current CEO of Johnson & Johnson.
Leadership matters because R&D allocation, patent strategy, acquisitions, litigation management, and global commercialization determine long-term growth.
Johnson & Johnson's profile includes a leadership timeline with current and former executives.